Yongming Qu

Company: Eli Lilly

Job title: Vice President, Research Statistics

Seminars:

Driving Early Success in Diabetes & Obesity Drug Development: Choosing the Optimal Drug Candidate with Model-Based Strategy to Reduce Risk & Accelerate Go/No-Go Decisions 9:30 am

How model-based approaches were used to enable a Multiple Ascending Dose (MAD) study to serve as an early proof of concept in diabetes/obesity drug development Using pharmacometrics modeling to evaluate drug behavior and guide go/no-go decisions before progressing to costly Phase 2 trials Real-world application: A case study illustrating how modeling accelerated candidate selection and…Read more

day: Day 1